The present status of chloroquine in the drug treatment of malaria.
D002738:Chloroquine / Q000009:adverse effects / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D008288:Malaria / Q000188:drug therapy* / Q000517:prevention & control; D010961:Plasmodium / Q000187:drug effects; D011319:Primaquine / Q000627:therapeutic use; D002727:Proguanil / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D011796:Quinacrine / Q000009:adverse effects / Q000627:therapeutic use; D011803:Quinine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use
D013449:Sulfonamides; D013450:Sulfones; D014227:Triazines; D002738:Chloroquine; D011803:Quinine; D011796:Quinacrine; D011319:Primaquine; D002727:Proguanil; D011739:Pyrimethamine